Objectives: The Antimicrobial Self-Assessment Toolkit for National Health Service (NHS) Trusts (ASAT) was developed to evaluate hospital-based antimicrobial stewardship programmes. Iterative validity investigations of the ASAT were used to produce a 91-item ASAT v17 utilizing qualitative methodology. Rasch analysis was used to generate question (item) behaviour estimates and to investigate the validity of ASAT v17.
Introduction
Antimicrobial resistance (AMR) remains a global public health concern.
1 It has been identified as one of the greatest threats to human health due to the emergence of MDR and pan-drugresistant bacteria, which restricts available antimicrobial therapeutic options. 2 -4 Substantial clinical and economic burdens have been associated with the prevalence of AMR within health systems. 1 For example, the US CDC has estimated that 2 million people acquire serious antimicrobial-resistant infections resulting in 23000 deaths each year. Additionally, there has been significant financial expenditure of 21 -34 billion US dollars per year due to these infections. However, the CDC has cautioned that these clinical and financial estimates maybe conservative. 1, 5 Both national and international initiatives such as the Transatlantic Taskforce on Antimicrobial Resistance have been developed to combat AMR by addressing inappropriate use of antimicrobials in medicine and the rates of healthcare-associated infections including Clostridium difficile. 3 In addition, the WHO has recommended that prudent utilization of fluoroquinolones, third-and fourthgeneration cephalosporins, macrolides and glycopeptides should be prioritized, internationally. 6 Hospital-based strategies have been devised to reduce AMR incidence including the development and implementation of antimicrobial stewardship programmes (ASPs). 7 Composed of interventions ranging from antimicrobial committees to utilizing restrictive formularies, ASPs have become an established method of promoting prudent antimicrobial prescribing within hospitals in England and internationally. 8 -10 However, the selection, prioritization and implementation of interventions for promoting prudent antimicrobial prescribing are context-dependent, and will differ across National Health Service (NHS) Trusts in England. 11, 12 In addition to reducing AMR, numerous reasons exist for the promotion of prudent antimicrobial prescribing through hospital-based ASPs. First, it has been estimated that 50% of hospital-based antimicrobial prescribing is inappropriate, and this has been implicated in the development of C. difficile infection. 13 -19 Common examples of inappropriate prescribing include delayed administration for critically ill patients and antimicrobial therapy with an inappropriate spectrum of activity. 20 Other reasons include the paucity of novel antimicrobial agents under development by the pharmaceutical industry and costs associated with antimicrobial overconsumption.
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Instrument development and validity testing
The Antimicrobial Self-assessment Toolkit for NHS Trusts (ASAT) was developed by an advisory non-departmental public body on Antimicrobial Resistance and Healthcare Associated Infections (ARHAI) and the Department of Health (see Table 1 ). 23 The primary purpose of the ASAT is to identify and to assess interventions used to implement antimicrobial stewardship within NHS Trusts. It embodies the relevant published studies and guidelines relating to antimicrobial stewardship, AMR and infection control translating them into a single workable document. 23 More recently, 'Antimicrobial Stewardship: Start Smart-then Focus' was published by ARHAI with the aim to provide NHS hospitals with an outline for evidence-based antimicrobial stewardship. 24 Face and content validity testing have been conducted on previous versions of the ASAT utilizing qualitative methodology, e.g. cognitive interviewing techniques with hospital-based antimicrobial pharmacists and consultant clinical microbiologists. 11, 12, 23 The findings from these studies supported validity arguments and were used iteratively to modify and improve the validity of the ASAT, and hence produce ASAT v17. However, these qualitative approaches were unable to generate estimates of item (question) behaviour within a measurement model; therefore, Rasch analysis was used for this purpose and is described in the Materials and methods section.
Why validity?
It has been recommended that validity should be viewed as a unitary concept, which is derived from evidence such as content and construct validity. 25, 26 Validity can be defined as the extent to which a questionnaire measures what it is intended to measure and testing is required because derived inferences about the target population will be based on questionnaire scores. 27, 28 Utilizing measurement models, validity arguments can be strengthened 'if the degree of fit of the information with the theoretical rationale underlying score interpretation is explicitly evaluated'. 29 Hence, the aim of this study was to investigate the validity of ASAT v17.
Materials and methods
This was a cross-sectional study that evaluated ASPs within 33 NHS Trusts in England. Data were collected using ASAT v17 with a purposive sample of hospital-based antimicrobial pharmacists (n¼31) and consultant clinical microbiologists (n ¼2) between January and June 2012. Most respondents (NHS Trusts) who agreed to take part in the study worked within the largest Strategic Health Authority in England, i.e. Northwest Strategic Health Authority.
ASAT instrument properties
ASAT v17 was a 91-item (question) instrument that contained eight domains, including clinical governance assurance (see Table 1 ). It was composed of dichotomous items with two response options (e.g. yes ¼ 1; no ¼ 0) and polytomous items with more than two response options (e.g. 3 for ≥80%; 2 for .50% -80%; 1 for .30% -50%; 0 for ≤30%). ASAT v17 is available as Supplementary data at JAC Online.
Rasch analyses
Data analyses were conducted within the Rasch measurement framework, which is based on item response theory and followed guidelines for instrument construction and validation. 30 -32 It specifies that there should be an expected pattern of responses if measurement is to be achieved. 29 The Rasch mathematical model is based on the probability of a favourable response and provides estimates of item difficulty (d i ) and respondent ability (b n ) (see Equation 1) . It permits d i and b n to be located on the same scale within the range of +infinity and models the Validation of ASAT v17 using Rasch analysis JAC probability (P) of responding favourably on item (i) for each participating NHS Trust (n). This probability is expressed as follows:
The probability (P) that a NHS Trust will endorse, or respond favourably, to an item within ASAT v17 is modelled as a function of the difference between each NHS Trust's ability (b n ) and item difficulty (d i ). The partial credit model (PCM) was utilized because it can analyse instruments with dichotomous and polytomous items. It rewards 'partial credit' for intermediate responses that lie between two extremes and allows dichotomous and polytomous response options to be analysed simultaneously. 29 Rasch assumptions, including unidimensionality and item discrimination, were investigated using the PCM. 33 Unidimensionality refers to the measurement of a single trait or attribute at a time, hence, it provides evidence for construct validity, and can be assessed using fit statistics (see below). 29 Item discrimination refers to the ability of items within an instrument to discriminate between respondents with greater or lesser ability. 34 
WINSTEPS
w was used to analyse the resulting dataset generated from ASAT responses. It performs a logarithmic transformation of item and respondent data (raw scores) to yield an interval scale. 35 ASAT items receiving the same score, e.g. (yes ¼ 1) from each respondent were dropped from the analysis by WINSTEPS w due to their inability to discriminate between respondents. Other WINSTEPS w outputs, including respondent/item maps, were examined in conjunction with the fit indices (see below). These maps are a visual representation of item and respondent behaviour by locating each NHS Trust on a logit scale. Ceiling effects occurred when most respondents were located at the top of the operational range for within ASAT domains, i.e. NHS Trusts achieved the maximum score for the domain. Floor effects are the converse of this phenomenon where most respondents located at the bottom of the scale.
Fit statistics (analysis of fit)
Fit statistics such as Infit mean square (INFIT MNSQ) were used to investigate item fit, i.e. to indicate the degree of fit of ASAT items (questions) to the expectations of the PCM. 29 INFIT MNSQ statistics are inlier patternsensitive fit statistics and are based on the x 2 statistic with each observation weighted by its model variance.
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ASAT items that were productive for measurement (i.e. INFIT MNSQ between 0.7 and 1.3) possessed the ability to discriminate between NHS Trusts within the study sample (see Table 2 ). Conversely, items that were unproductive for measurement (i.e. INFIT MNSQ ,0.7 or .1.3) lacked the ability to discriminate between NHS Trusts and were categorized as misfitting, i.e. overfitting or underfitting the PCM (see Table 2 ).
Data analyses were conducted using a three-step approach.
Step 1 involved analysis of the fit statistics of items within each ASAT sub-scale/ domain, Step 2 involved iterative removal of misfitting items and recalibration followed by rechecking the INFIT MNSQ values for the remaining items within each sub-scale. This procedure was repeated iteratively until all remaining items demonstrated good fit within the PCM. Data triangulation using qualitative data from previous validity testing was conducted to explain item behaviour, retention or deletion, if indicated. 11, 12, 23 Step 3 involved analysis of the entire item pool of ASAT v17 (scale analysis), item and respondent reliability indices. 33 
Regression analysis
Ordinary least squares (OLS) regression modelling was used to investigate the predictive validity of the ASAT using SPSS v20. 37 The ability (b n ) estimates (i.e. the measures for the NHS Trusts within each validated ASAT sub-scale and the overall scale) generated from Rasch analysis was the predictor variable and NHS Trust C. difficile rates was the outcome variable. 38 
Ethics
Ethics approval from the University of Manchester Research Ethics Committee was deemed unnecessary at the time of the study, because it was categorized by the NHS Research and Development service as a service evaluation.
Results
Sub-scale analyses: examination of fit statistics
Generally, it was observed that there was good item fit within each domain; however, some misfitting items were present. Illustrative examples of item behaviour are presented below. Table 3 ). Recalibration after the iterative removal of Q1.3 and Q1.4 resulted in increased misfit of the remaining items within Domain 1, e.g. Q1.2 INFIT MNSQ increased from 1.08 to 1.71. Multidimensionality was exhibited when both of these items were removed together, which violated the assumption of unidimensionality. In other words, it resulted in a sub-scale that appeared to measure multiple constructs. Table 3 ), hence these items were dropped from the analysis. These questions were related to utilization of the antimicrobial policies and treatment guidelines within NHS Trusts. Not surprisingly, each NHS Trust indicated that they used these documents as part of their ASP implementation strategy; however, it was observed that Q2.17 (INFIT MNSQ ¼ 1.63) (see Table 3 ) was underfitting the PCM. Item Q2.18 (INFIT MNSQ ¼ 0.39) (see Table 3 ) appeared to be overfitting hence providing redundant information. Iterative item removal resulted in a relatively small (negligible) effect on the overall fit indices for Domain 2; therefore, these items were retained for further investigation (scale analyses).
Domain 3. Risk assessment for antimicrobial chemotherapy
All items had INFIT MNSQ statistics between 0.79 and 1.23 (see Table 4 ), thus, fitting the PCM and consequently fulfilling the assumption of unidimensionality. Therefore, suggesting that they measure the unitary concept of risk assessment for antimicrobial chemotherapy. Ceiling effects were observed on examination of the item/respondent map because most respondents were located at the top of the operational range for this domain. In other words, most NHS Trusts reported that they utilized implementation strategies for risk assessment for antimicrobial chemotherapy, which were targeted by ASAT v17. Consequently, Domain 3 had very limited item discrimination due to its inability to discriminate between NHS Trusts, which resulted in the observed ceiling effects.
Domain 4. Clinical governance and audit
Item Q4.1 (INFIT MNSQ ¼ 0.59) was slightly overfitting the model suggesting that this item could be redundant in Domain 4 (see Table 3 ). Item Q4.8 (INFIT MNSQ ¼ 1.45) was underfitting the model and therefore introducing 'noise' into the domain (see Table 3 ). Iterative item removal of Q4.1 and Q4.8 had negligible effects on the overall fit indices for Domain 4, i.e. INFIT MNSQ increased from 0.96 to 0.98. There was effective item targeting within this sub-scale because the item difficulty mean and the respondent ability mean were located close together on the logit scale of the item/respondent maps. This was an indication that this domain was a good, well-constructed measure due to its ability to discriminate between NHS Trusts.
Domain 5. Education and training
Items Q5.9 (INFIT MNSQ ¼1.70) and Q5.10a (INFIT MNSQ ¼ 1.69) were both underfitting the model (see Table 3 ). Qualitative data from previous validity testing indicated that such information is difficult to collect, which could account for the observed underfit. Iterative item removal resulted in a negligible change in the overall mean fit indices for this domain. All other items within this domain demonstrated good fit with INFIT MNSQ values ranging from 0.84 to 1.23. Are peer-reviewed, evidence-based, guidelines available for treatment of common infections? Q2. 9 Are full electronic versions available in all networked computers? Q2. 13 Do antimicrobial guidelines provide guidance on typical duration of treatment for each indication? Q6. 1 Is there a substantive antimicrobial pharmacist post in place within your department? Q7. 2 Are clinical microbiologists involved in the development of antimicrobial policies and guidelines?
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Domain 6. Antimicrobial pharmacist
Owing to the perfect scores achieved for item Q6.1 (see Table 3 ), it was dropped from the analysis by WINSTEPS w because all respondents indicated that their NHS Trust had an antimicrobial pharmacist in post. Item Q6.3 (INFIT MNSQ ¼ 1.53), which targeted the proportion of whole time equivalent antimicrobial pharmacists appeared to be underfitting the model (see Table 3 ). Item Q6.8 (INFIT MNSQ ¼ 0.57), which asked if the antimicrobial pharmacist had a yearly appraisal appeared to be a redundant item as it was overfitting the model (see Table 3 ). The removal of these items (i.e. Q6.3 and Q6.8) from the analysis did not significantly improve model fit so therefore they were retained for further analyses.
Domain 7. Clinical microbiologist
On examination of the fit statistics for Domain 7, it was observed that item Q7.6 (INFIT MNSQ ¼ 1.40) was underfitting the model (see Table 3 ). The removal of item Q7.6 caused other items to underfit the model; therefore, it was decided that this item should be retained for scale analysis. Most respondents obtained maximum scores to items in this domain, which resulted in a ceiling effect in the item/respondent map, indicating limited item discrimination.
Domain 8. Patients, carers and the public
Most items within Domain 8 appeared to have good fit with INFIT MNSQ statistics ranging from 0.99 to 1.24. However, there was a slight overfit observed with item Q8.6 (INFIT MNSQ ¼ 0.64), which could be due to respondents interpreting this question as a duplication of item Q8.3 (see Table 3 ). Both of the questions asked if patients received an explanation about the risks and side effects of antimicrobial chemotherapy, as an inpatient (Q8.3) and at discharge (Q8.6). However, on examination of the item/person map for Domain 8, a floor effect was observed, which indicated poor item discrimination for this domain because most respondents achieved minimum scores for this domain, i.e. '0 for ,30%' (see Figure 1 ). One possible explanation could relate to the difficulty associated with collating the data needed to respond to these questions.
Overall scale analysis
Pooled item analyses demonstrated that the ASAT measured the unitary concept under investigation, i.e. ASPs. Most items (n¼ 81) had INFIT MNSQ values between 0.79 and 1.23, which indicated that they were productive for measurement. This subset of items was used for predictive validity analyses and used to inform the first iteration of ASAT v18. All other items were unproductive for measurement and were either perfectly scored items or misfitting items. The item/respondent map showed that there was a good normal distribution of respondents; therefore, these items had the ability to discriminate between NHS Trusts by locating their ability along the logit scale (see Figure 2) . The respondent separation (2.55) and respondent reliability (0.87) scores indicated that it was sensitive enough to distinguish between high and low performing NHS Trusts. The item separation (2.81) and item reliability (0.89) scores indicated that the sample size was large enough to confirm item hierarchy.
Predictive validity
OLS regression modelling identified that there was limited predictive validity due to the small positive correlation between the two variables under investigation, i.e. NHS Trust ability estimates and C. difficile rates for participating hospitals (r ¼ 0.146; P ¼ 0.418) (see Figure 3) . The ability estimates (b n ) was an indication of whether NHS Trusts can respond favourably to ASAT items. The model only accounted for 2.1% of variation (R 2 ¼ 0.021) in the outcome variable, i.e. C. difficile rates. In other words, the model could not predict the effect of cumulative interventions within the ASAT on NHS Trust C. difficile rates. Bailey et al. Validation of ASAT v17 using Rasch analysis
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Discussion
The aim of this study was to investigate the validity of ASAT v17. It was found that there was evidence of construct validity but limited evidence of predictive validity. Rasch analysis was an effective diagnostic method for investigating assumptions such as unidimensionality (construct validity) of ASAT v17 at a sub-scale Bailey et al.
Some of the domains presented ceiling effects (e.g. Domains 1, 3, 7) and a floor effect in Domain 8, which affected the ability of these domains to discriminate well between NHS Trusts. The ceiling effects resulted from items being 'easy' to report compliance and conversely, the floor effect was due to participants' inability to achieve and/or report compliance to the items in Domain 8.
Within the Rasch measurement framework, the concept of 'fit' is viewed as a quality control mechanism and aids in the empirical determination of whether the assumption of unidimensionality is fulfilled within the model. 29 Misfitting, i.e. underfitting and/or overfitting items could be potentially problematic for the unidimensional construct because they have diverged from the expected ability or difficulty pattern. 36 Misfitting items negatively affect construct validity and may degrade the quality of the measurement achieved. These items may be examining other dimensions external to the instrument under investigation, i.e. ASAT v17. Overfitting items are overly predictable and may be indicative of linkage to other items within the same item pool, e.g. Q8.3 and Q8.6. Such items do not satisfy the Rasch assumption of local independence, i.e. the ability of items to work independently of each other within the ASAT. These items may lead to the conclusion that the instrument is better than it actually is, because they yield Guttmann-like responses. 29 Such responses are cumulative and dependent on each other within a unidimensional continuum. Hence, the Rasch assumption of local independence is not fulfilled because these responses may depend on one item or multiple items within the ASAT hence negatively affecting response accuracy. Overfitting items, e.g. Q4.1 often lack the ability to discriminate between respondents, hence not fulfilling the Rasch assumption of item discrimination. 39, 40 Construct underrepresentation and construct irrelevance variance are threats to unidimensionality, hence, construct validity. 41, 42 Construct underrepresentation occurs when the questionnaire is too narrow and fails to include important dimensions or facets of the construct under investigation. Hence, during item generation, it is possible to omit some components of the construct that can limit the score meaning and interpretation. 29 Conversely, construct irrelevance variance occur when the questionnaire is too broad, resulting in the unrelated sub-dimensions or concepts present in the questionnaire, which are irrelevant to the construct and could account for item misfit.
Based on these results, modifications were conducted on ASAT v17 to produce the final iteration of ASAT v18, which included indicating what items could be used for comparative analyses of ASPs, i.e. productive for measurement. Other modifications included the addition of appendices that signpost end-users to the guidelines and policies that underpin the toolkit, and the red -amber -green status to facilitate the interpretation of cumulative ASAT scores.
Strengths and limitations
Traditionally, Rasch analysis has been used in educational research and has been extensively applied to test development and attitudinal measurement. 25, 43, 44 To the authors' knowledge, this is the first study that investigated the validity of an organizational, hospital-based self-assessment instrument using Rasch analysis and OLS regression modelling. However, there are a number of limitations associated with this study. First, Rasch analysis is unable to produce statistical estimates for items that have been perfectly scored either negatively or positively by respondents because of the probabilistic nature of the model. 35 However, these items may target other processes that are needed to implement effective hospital-based ASPs. Second, the sample size was 33 of the 167 NHS Trusts, which equated to 20% of NHS Trusts in England at the time of participant recruitment. The proposed minimum sample size required for Rasch analysis is 30 respondents. 29 We ensured that the sample size is sufficient to provide useful item calibrations, which subsequently provided a useful level of measurement stability. 45 However, we recognize that small sample sizes could produce less precise estimates hence larger standard errors and imprecise estimates of fit. 45 Recently, there have been investigations conducted into the effect of smaller sample sizes on the precision of mean square fit statistics in PCM using polytomous data. 46 Not surprisingly, one conclusion was that sample size invariance may exist for mean square fit statistics and that larger sample sizes would increase the stability of Rasch models. 46 In addition, this study was conducted within NHS Trusts in England because the ASAT was designed to be used within this type of healthcare organization. The generalizability of the study is limited to NHS Trusts in England and may not be applicable to ASPs in ambulatory or community care settings. However, it is hoped to take the ASAT model into international settings and to develop it as part of a quality assurance instrument for antimicrobial stewardship assessment within hospitals.
Rasch analysis was an effective approach for guiding the development of the ASAT and improving measurement properties and reducing respondent burden. Iterative sub-scale calibrations identified which items were productive for measurement that could potentially be used for comparative analysis between NHS Trusts. The ASAT provides a relatively simple instrument for hospitals to assess their level of antimicrobial stewardship and can offer patients, carers and the public an insight into how well their hospitals are performing in this area. Validation of ASAT v17 using Rasch analysis JAC
